Delayed fas‐mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNFα

Fas‐mediated apoptosis is one of the major death processes of hepatocytes in liver diseases. Although compensatory regeneration occurs during liver injury, it has not been determined whether regenerating hepatocytes die by the same apoptotic process as quiescent hepatocytes. To clarify this issue, the hepatocyte apoptotic process, after injection of agonistic anti‐mouse Fas, was compared between sham‐operated mice and two‐thirds partially hepatectomized mice. The onset of hepatocyte apoptosis was retarded in hepatectomized mice, as evidenced by both morphological and biochemical observations, resulting in significantly prolonged animal survival. Flow cytometric analysis revealed similar levels of Fas expression on hepatocytes between hepatectomized mice and sham‐operated mice; however, the activation of liver caspase‐3‐like protease after Fas stimulation was suppressed in hepatectomized mice, whereas pro‐caspase‐3 expression did not change with or without hepatectomy. Anti‐tumor necrosis factor alfa (TNFα), when administered before hepatectomy, partially reversed suppression of caspase‐3‐like activity after Fas stimulation. Furthermore, the injection of TNFα into untreated mice suppressed caspase‐3‐like activity and prolonged animal survival after Fas stimulation. These results indicate that Fas‐signaling events at the level or upstream of caspase‐3‐like protease are suppressed during liver regeneration, resulting in delayed hepatocyte apoptosis, and also that TNFα acts as one of the protective factors against Fas‐mediated hepatocyte apoptosis.

[1]  Howard Y. Chang,et al.  Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis , 1997, Cell.

[2]  C. Thompson,et al.  Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Nagata,et al.  Essential roles of the Fas ligand in the development of hepatitis , 1997, Nature Medicine.

[4]  J. Peschon,et al.  Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[6]  G. Michalopoulos,et al.  Liver Regeneration , 1997, Science.

[7]  Y. Hannun Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.

[8]  John Calvin Reed,et al.  Modulation of apoptosis-associated genes bcl-2, bcl-x, and bax during rat liver regeneration. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[9]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[10]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[11]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[12]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[13]  N. Miyasaka,et al.  Ceramide induces apoptosis via CPP32 activation , 1996, FEBS letters.

[14]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[15]  David Wallach,et al.  Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.

[16]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[17]  S. Nagata,et al.  Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.

[18]  R. Taub Transcriptional control of liver regeneration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  R. Rai,et al.  Regulation of signal transduction during liver regeneration , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  S. Orrenius,et al.  CPP32/Apopain Is a Key Interleukin 1 Converting Enzyme-like Protease Involved in Fas-mediated Apoptosis (*) , 1996, The Journal of Biological Chemistry.

[21]  N. Hayashi,et al.  Fas antigen expression in liver tissues of patients with chronic hepatitis B. , 1996, Journal of hepatology.

[22]  N. Fausto,et al.  Role of growth factors and cytokines in hepatic regeneration , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  P. Galle,et al.  Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.

[24]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[25]  M. Leist,et al.  Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. , 1995, Gastroenterology.

[26]  M. Leist,et al.  Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. , 1995, The American journal of pathology.

[27]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[28]  N. Hayashi,et al.  Role of Fas ligand in apoptosis induced by hepatitis C virus infection. , 1994, Biochemical and biophysical research communications.

[29]  D. Brenner,et al.  Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. , 1994, The American journal of physiology.

[30]  J. Tschopp,et al.  Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.

[31]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[32]  E. O’Neill,et al.  T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.

[33]  P. Godowski,et al.  In vivo response of hepatocytes to growth factors requires an initial priming stimulus , 1994, Hepatology.

[34]  N. Hayashi,et al.  Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C , 1993, Hepatology.

[35]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[36]  S. Nagata,et al.  Effect of bcl-2 on Fas antigen-mediated cell death. , 1993, Journal of immunology.

[37]  H. Tsutsui,et al.  Importance of direct hepatocytolysis by liver macrophages in experimental fulminant hepatitis. , 1992, Hepato-gastroenterology.

[38]  C. McClain,et al.  Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. , 1992, The American journal of physiology.

[39]  H. Horvitz,et al.  Mechanisms and functions of cell death. , 1991, Annual review of cell biology.

[40]  A. Wendel,et al.  Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. , 1989, Biochemical pharmacology.

[41]  P. Seglen Preparation of isolated rat liver cells. , 1976, Methods in cell biology.

[42]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[43]  R. Anderson,et al.  Experimental pathology of liver: restoration of liver in white rat following partial surgical removal , 1931 .

[44]  G. Higgins,et al.  Experimental pathology of the liver , 1931 .